H.R. 8646IntroducedHouseSenate · nowPresidentLawIn the SenateSec. 783 · H.R. 8646
Untitled section
Title VII — GENERAL PROVISIONS
Read this section in the full bill →
This section appears in one version only, so there is nothing to compare yet.
None of the funds made available by this Act may be used in contravention of section 506C(g) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356c(g)) with respect to the review of an application or supplement, or the inspection or reinspection of an establishment, that could help mitigate or prevent a shortage of a sterile injectable drug used in cancer treatment and listed as being in shortage by the Food and Drug Administration.